Adhesion molecules as diagnostic and severity biomarkers in pediatric community-acquired pneumonia.
adhesion molecules
community-acquired pneumonia
diagnosis of pneumonia
pediatric
Journal
The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
revised:
09
09
2020
received:
27
10
2019
accepted:
19
01
2021
pubmed:
24
1
2021
medline:
17
7
2021
entrez:
23
1
2021
Statut:
ppublish
Résumé
Discrimination of the cases with severe and mild pneumonia is crucial due to the requirement of hospitalization, additional management, and treatment protocols. We aimed to analyze the role of IL6 (Interleukin), IL8, IL10, VCAM-1 (soluble Vascular Cell Adhesion Molecule), and sSELE (soluble E-selectin) in the diagnosis and prognostic evaluation of community-acquired pneumonia (CAP). Pediatric patients with severe pneumonia (SP) were hospitalized and patients with mild disease (MP) were treated in the community. IL6, IL8, IL10, VCAM-1, and sSELE levels of the patients were investigated and compared with the age- and gender-matched healthy subjects. A total of 113 patients fulfilling the criteria for a diagnosis of CAP were enrolled in the study, 62 (54.8%) of which had SP and 51 (45%) had MP. MP and SP groups were significantly different in terms of IL8, IL10, and sSELE levels. Patients with SP and MP had significantly different WBC, ESR, and CRP values, as well. Besides classical acute phase parameters, inflammatory response parameters such as IL6 and VCAM-1 levels may be helpful in diagnosis of pneumonia. In terms of determination of disease severity in pediatric CAP, systemic inflammatory markers like IL8 and IL10 and adhesion molecules like sSELE seem useful in clinical settings.
Sections du résumé
BACKGROUND
BACKGROUND
Discrimination of the cases with severe and mild pneumonia is crucial due to the requirement of hospitalization, additional management, and treatment protocols. We aimed to analyze the role of IL6 (Interleukin), IL8, IL10, VCAM-1 (soluble Vascular Cell Adhesion Molecule), and sSELE (soluble E-selectin) in the diagnosis and prognostic evaluation of community-acquired pneumonia (CAP).
METHODS
METHODS
Pediatric patients with severe pneumonia (SP) were hospitalized and patients with mild disease (MP) were treated in the community. IL6, IL8, IL10, VCAM-1, and sSELE levels of the patients were investigated and compared with the age- and gender-matched healthy subjects.
RESULTS
RESULTS
A total of 113 patients fulfilling the criteria for a diagnosis of CAP were enrolled in the study, 62 (54.8%) of which had SP and 51 (45%) had MP. MP and SP groups were significantly different in terms of IL8, IL10, and sSELE levels. Patients with SP and MP had significantly different WBC, ESR, and CRP values, as well.
CONCLUSIONS
CONCLUSIONS
Besides classical acute phase parameters, inflammatory response parameters such as IL6 and VCAM-1 levels may be helpful in diagnosis of pneumonia. In terms of determination of disease severity in pediatric CAP, systemic inflammatory markers like IL8 and IL10 and adhesion molecules like sSELE seem useful in clinical settings.
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
522-529Subventions
Organisme : Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
ID : 216S316
Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Andonegui G, Zhou H, Bullard D, et al. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest. 2009;119:1921-1930.
Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584-589.
Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society concensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1:S27-S72.
Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66:1-23.
Nácher M, Blázquez AB, Shao B, et al. Physiological contribution of CD44 as a ligand for E-Selectin during inflammatory T-cell recruitment. Am J Pathol. 2011;178:2437-2446.
de Stoppelaar SF, van’t Veer C, van den Boogaard FE, et al. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb Haemost. 2013;110:582-592.
Surewaard BG, Trzciński K, Jacobino SR, et al. Pneumococcal immune evasion: ZmpC inhibits neutrophil influx. Cell Microbiol. 2013;15:1753-1765.
Ramos-Sevillano E, Urzainqui A, de Andrés B, et al. PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease. PLoS Pathog. 2016;14(12):e1005500.
de Stoppelaar SF, Van't Veer C, Roelofs JJ, et al. Platelet and endothelial cell P selectin are required for host defence against Klebsiella pneumoniae induced pneumosepsis. J Thromb Haemost. 2015;13:1128-1138.
Schuetz P, Stolz D, Mueller B, et al. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia. BMC Infect Dis. 2008;28(8):22.
Mendez MP, Monroy YK, Du M, et al. Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia. Respir Res. 2011;19(12):12.
Chang PY, Tsao SM, Chang JH, et al. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia. Clin Chim Acta. 2016;463:174-180.
Burón E, Garrote JA, Arranz E, Oyágüez P, Fernández Calvo JL, Blanco QA. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. Allergol Immunopathol (Madr). 1999;27:11-17.
Bacci MR, Leme RC, Zing NP, et al. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients. Braz J Med Biol Res. 2015;48:427-432.
Hsieh YC, Chi H, Chang KY, et al. Taiwan Pediatric Infectious Diseases Alliance. Increase in fitness of Streptococcus pneumoniae is associated with the severity of necrotizing pneumonia. Pediatr Infect Dis J. 2015;34:499-505.
Davey RT Jr, Lynfield R, Dwyer DE, et al. INSIGHT FLU 002 & 003 Study Groups. The association between serum biomarkers and disease outcome in influenza A (H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013;8:e57121.
Vasconcellos ÂG, Clarêncio J, Andrade D, Cardoso MA, Barral A, Nascimento-Carvalho CM. Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia. Cytokine. 2018;107:1-8.
Menéndez R, Torres A, Zalacaín R, et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960-965.
Menéndez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalized community acquired pneumonia. Thorax. 2008;63:447-452.
Janssens JP, Krause KH. Pneumonia in the very old. Lancer Infect Dis. 2004;4:112-124.
Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174:84-93.
Masiá M, Gutiérrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005;128:2223-2229.
Khan F, Owen MB, Restrepo M, Povoa P, Martin-Loeches I. Tools for outcome prediction in patients with community acquired pneumonia. Expert Rev Clin Pharmacol. 2017;10:201-211.